ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
rikki
|
90 |
28K |
5 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
90
|
28K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia Therapeutics Ltd- Announces $2 Million Registered Direct Offering
|
|
rikki
|
9 |
3.3K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
9
|
3.3K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
rikki
|
90 |
28K |
1 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
90
|
28K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
rikki
|
21 |
6.3K |
1 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
21
|
6.3K
|
1
|
|
International Markets
|
|
Re:
Kazia
|
|
rikki
|
12 |
2.9K |
1 |
17/11/23 |
17/11/23 |
International Markets
|
12
|
2.9K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Removal from Official List
|
|
rikki
|
2 |
972 |
6 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
2
|
972
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Suspension from Official List
|
|
rikki
|
8 |
1.8K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
8
|
1.8K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
rikki
|
71 |
18K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
71
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
rikki
|
71 |
18K |
1 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
71
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
rikki
|
10 |
3.2K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
10
|
3.2K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces Clinical Data at ESMO 2023 from EVT801 Study
|
|
rikki
|
2 |
1.0K |
2 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
rikki
|
54 |
17K |
4 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
54
|
17K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
rikki
|
30 |
9.6K |
6 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
30
|
9.6K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
rikki
|
2.0K |
618K |
4 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
2.0K
|
618K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
rikki
|
2.0K |
618K |
2 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
2.0K
|
618K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Acceptance of late-breaking abstract of PNOC022 data
|
|
rikki
|
7 |
2.2K |
3 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
7
|
2.2K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
rikki
|
2.0K |
618K |
7 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
618K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Kazia Share Price
|
|
rikki
|
791 |
216K |
5 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
791
|
216K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
rikki
|
22 |
6.3K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
22
|
6.3K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
rikki
|
22 |
6.3K |
2 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
22
|
6.3K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
rikki
|
22 |
6.3K |
8 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
22
|
6.3K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Comparisions other Drug Companies
|
|
rikki
|
6 |
2.5K |
2 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
rikki
|
103 |
38K |
6 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
103
|
38K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
rikki
|
103 |
38K |
4 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
103
|
38K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
rikki
|
20 |
6.5K |
0 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.5K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces change to Board of Directors
|
|
rikki
|
20 |
6.5K |
3 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20
|
6.5K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
top 20
|
|
rikki
|
27 |
10K |
6 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
27
|
10K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
rikki
|
103 |
38K |
1 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
103
|
38K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
rikki
|
10 |
2.9K |
0 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
10
|
2.9K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
rikki
|
42 |
12K |
2 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia's Paxalisib Receives Fast Track Designation From FDA For Treatment Of Solid Tumor...
|
|
rikki
|
14 |
4.3K |
0 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
14
|
4.3K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
rikki
|
103 |
38K |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
103
|
38K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
rikki
|
27 |
7.7K |
0 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
27
|
7.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
rikki
|
27 |
7.7K |
1 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
27
|
7.7K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
rikki
|
27 |
7.7K |
0 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
27
|
7.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
rikki
|
23 |
6.8K |
2 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
23
|
6.8K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
rikki
|
23 |
6.8K |
8 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
23
|
6.8K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
rikki
|
23 |
6.8K |
2 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
23
|
6.8K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
rikki
|
34 |
11K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appointment of Non-executive Director
|
|
rikki
|
4 |
1.7K |
3 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
rikki
|
34 |
11K |
2 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
34
|
11K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
rikki
|
34 |
11K |
6 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
34
|
11K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
rikki
|
34 |
11K |
0 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
rikki
|
34 |
11K |
4 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
34
|
11K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
rikki
|
55 |
17K |
4 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
55
|
17K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
rikki
|
55 |
17K |
10 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
55
|
17K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
rikki
|
55 |
17K |
2 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
55
|
17K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
rikki
|
55 |
17K |
6 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
55
|
17K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
rikki
|
55 |
17K |
1 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
55
|
17K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
rikki
|
6 |
2.0K |
8 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
6
|
2.0K
|
8
|
|